GSK plc is 10% Owner at Wave Life Sciences Ltd. (WVE). They have made 3 open-market trades across 1 company since 2023, most recently 2025-12-11.
3 open-market purchases totalling $66.8M since 2023, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| WVE | 18,245,691 | $57.1M |
Shares reported on the most recent Form 4, priced at the 2025-12-15 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.